Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SlowMag is an over-the-counter oral mineral supplement product containing calcium carbonate and magnesium chloride, marketed to prevent or treat low magnesium states and to provide supplemental magnesium and calcium intake when dietary intake is inadequate or mineral losses are increased. It is a combination small-molecule mineral formulation rather than a targeted therapeutic; its clinical effect derives from replenishing systemic magnesium and calcium needed for normal neuromuscular, cellular, and cardiac function, with magnesium chloride selected for supplementation and an enteric or delayed-release design used in some formulations to improve gastrointestinal tolerability. The product is used primarily for hypomagnesemia prevention or correction and general mineral supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SlowMag.